Corline Biomedical AB Statistics
Total Valuation
STO:CLBIO has a market cap or net worth of SEK 365.86 million. The enterprise value is 340.36 million.
Important Dates
The next estimated earnings date is Tuesday, February 16, 2027.
| Earnings Date | Feb 16, 2027 |
| Ex-Dividend Date | n/a |
Share Statistics
STO:CLBIO has 26.13 million shares outstanding. The number of shares has increased by 7.39% in one year.
| Current Share Class | 26.13M |
| Shares Outstanding | 26.13M |
| Shares Change (YoY) | +7.39% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 45.03% |
| Owned by Institutions (%) | 16.65% |
| Float | 11.31M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 27.22 |
| PB Ratio | 3.88 |
| P/TBV Ratio | 3.88 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 25.33 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.52, with a Debt / Equity ratio of 0.05.
| Current Ratio | 6.52 |
| Quick Ratio | 6.13 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -18.09 |
Financial Efficiency
Return on equity (ROE) is -16.03% and return on invested capital (ROIC) is -9.34%.
| Return on Equity (ROE) | -16.03% |
| Return on Assets (ROA) | -14.40% |
| Return on Invested Capital (ROIC) | -9.34% |
| Return on Capital Employed (ROCE) | -12.71% |
| Weighted Average Cost of Capital (WACC) | 5.99% |
| Revenue Per Employee | 959,929 |
| Profits Per Employee | -981,286 |
| Employee Count | 14 |
| Asset Turnover | 0.14 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -27.27% in the last 52 weeks. The beta is 0.30, so STO:CLBIO's price volatility has been lower than the market average.
| Beta (5Y) | 0.30 |
| 52-Week Price Change | -27.27% |
| 50-Day Moving Average | 14.10 |
| 200-Day Moving Average | 16.19 |
| Relative Strength Index (RSI) | 49.99 |
| Average Volume (20 Days) | 28,209 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, STO:CLBIO had revenue of SEK 13.44 million and -13.74 million in losses. Loss per share was -0.53.
| Revenue | 13.44M |
| Gross Profit | 11.44M |
| Operating Income | -13.13M |
| Pretax Income | -13.74M |
| Net Income | -13.74M |
| EBITDA | -13.00M |
| EBIT | -13.13M |
| Loss Per Share | -0.53 |
Full Income Statement Balance Sheet
The company has 29.87 million in cash and 4.36 million in debt, with a net cash position of 25.51 million or 0.98 per share.
| Cash & Cash Equivalents | 29.87M |
| Total Debt | 4.36M |
| Net Cash | 25.51M |
| Net Cash Per Share | 0.98 |
| Equity (Book Value) | 94.23M |
| Book Value Per Share | 3.61 |
| Working Capital | 28.46M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -15.37 million and capital expenditures -376,000, giving a free cash flow of -15.74 million.
| Operating Cash Flow | -15.37M |
| Capital Expenditures | -376,000 |
| Depreciation & Amortization | 132,000 |
| Net Borrowing | 9.13M |
| Free Cash Flow | -15.74M |
| FCF Per Share | -0.60 |
Full Cash Flow Statement Margins
Gross margin is 85.14%, with operating and profit margins of -97.72% and -102.22%.
| Gross Margin | 85.14% |
| Operating Margin | -97.72% |
| Pretax Margin | -102.22% |
| Profit Margin | -102.22% |
| EBITDA Margin | -96.73% |
| EBIT Margin | -97.72% |
| FCF Margin | n/a |
Dividends & Yields
STO:CLBIO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -7.39% |
| Shareholder Yield | -7.39% |
| Earnings Yield | -3.80% |
| FCF Yield | -4.30% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
STO:CLBIO has an Altman Z-Score of 16.76 and a Piotroski F-Score of 3.
| Altman Z-Score | 16.76 |
| Piotroski F-Score | 3 |